Literature DB >> 30622783

Clinical features of Mycoplasma pneumoniae coinfection and need for its testing in influenza pneumonia patients.

Jung Heon Kim1, Jae Hyun Kwon2, Jeong-Yong Lee3, Jong Seung Lee1, Jeong-Min Ryu1, Sung-Han Kim4, Kyoung Soo Lim1, Won Young Kim1.   

Abstract

BACKGROUND: To investigate the clinical features of coinfection due to Mycoplasma pneumoniae (M. pneumoniae), a common copathogen in influenza, in influenza pneumonia patients.
METHODS: We reviewed 4,465 patients with influenza who visited a tertiary care hospital emergency department in Seoul (Korea) from 2010 through 2016, and underwent immunoglobulin M (IgM) serology or polymerase chain reaction (PCR) for M. pneumoniae. Influenza pneumonia was defined as laboratory-confirmed influenza plus radiographic pneumonia. Patients with healthcare-associated pneumonia or non-mycoplasma bacterial coinfection were excluded. Clinical, laboratory, and radiographic findings and outcomes of the influenza pneumonia patients with and without M. pneumoniae coinfection were compared. Multivariable logistic regression analysis was performed to identify factors associated with the coinfection.
RESULTS: Of 244 influenza pneumonia patients, 41 (16.8%) had M. pneumoniae coinfection. These patients were younger with a higher frequency of age of 5-10 years, and had higher white blood cell (WBC) and lymphocyte counts; lower concentration of C-reactive protein (CRP). The coinfection had no association with specific radiographic findings and poor outcome. Multivariable analysis showed the age of 5-10 years (adjusted odds ratio, 18.83; 95% confidence interval, 5.899-60.08; P<0.001) as the factor associated with the coinfection.
CONCLUSIONS: M. pneumoniae coinfection in influenza pneumonia may be associated with the age of 5-10 years, and otherwise clinically indistinct from influenza pneumonia without the coinfection. This finding suggests the need for M. pneumoniae testing in patients aged 5-10 years with influenza pneumonia.

Entities:  

Keywords:  Child; coinfection; influenza, human; pneumonia, bacterial; pneumonia, mycoplasma

Year:  2018        PMID: 30622783      PMCID: PMC6297417          DOI: 10.21037/jtd.2018.10.33

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN: 2072-1439            Impact factor:   2.895


  28 in total

1.  Mycoplasma pneumoniae pneumonia: radiographic and high-resolution CT features in 28 patients.

Authors:  P Reittner; N L Müller; L Heyneman; T Johkoh; J S Park; K S Lee; O Honda; N Tomiyama
Journal:  AJR Am J Roentgenol       Date:  2000-01       Impact factor: 3.959

2.  Chlamydia pneumoniae pneumonia and Mycoplasma pneumoniae pneumonia: comparison of clinical findings and CT findings.

Authors:  Fumito Okada; Yumiko Ando; Masaki Wakisaka; Shunro Matsumoto; Hiromu Mori
Journal:  J Comput Assist Tomogr       Date:  2005 Sep-Oct       Impact factor: 1.826

3.  Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults.

Authors:  Lionel A Mandell; Richard G Wunderink; Antonio Anzueto; John G Bartlett; G Douglas Campbell; Nathan C Dean; Scott F Dowell; Thomas M File; Daniel M Musher; Michael S Niederman; Antonio Torres; Cynthia G Whitney
Journal:  Clin Infect Dis       Date:  2007-03-01       Impact factor: 9.079

Review 4.  Mycoplasma pneumoniae and its role as a human pathogen.

Authors:  Ken B Waites; Deborah F Talkington
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

Review 5.  Complications of seasonal and pandemic influenza.

Authors:  Michael B Rothberg; Sarah D Haessler
Journal:  Crit Care Med       Date:  2010-04       Impact factor: 7.598

6.  Impact of the rapid diagnosis of influenza on physician decision-making and patient management in the pediatric emergency department: results of a randomized, prospective, controlled trial.

Authors:  Aleta B Bonner; Kathy W Monroe; Lynya I Talley; Ann E Klasner; David W Kimberlin
Journal:  Pediatrics       Date:  2003-08       Impact factor: 7.124

7.  Use of simple heuristics to target macrolide prescription in children with community-acquired pneumonia.

Authors:  Joachim E Fischer; Felicitas Steiner; Franziska Zucol; Christoph Berger; Laura Martignon; Walter Bossart; Martin Altwegg; David Nadal
Journal:  Arch Pediatr Adolesc Med       Date:  2002-10

Review 8.  Clinical review: primary influenza viral pneumonia.

Authors:  Jordi Rello; Aurora Pop-Vicas
Journal:  Crit Care       Date:  2009-12-21       Impact factor: 9.097

9.  Polymerase chain reaction is superior to serology for the diagnosis of acute Mycoplasma pneumoniae infection and reveals a high rate of persistent infection.

Authors:  Anna C Nilsson; Per Björkman; Kenneth Persson
Journal:  BMC Microbiol       Date:  2008-06-11       Impact factor: 3.605

Review 10.  Community-acquired pneumonia.

Authors:  Thomas M File
Journal:  Lancet       Date:  2003-12-13       Impact factor: 79.321

View more
  6 in total

1.  The Prevalence of Mycoplasma Pneumoniae Among Children in Beijing Before and During the COVID-19 Pandemic.

Authors:  Yuan Cheng; Yijing Cheng; Shuzhi Dai; Dongqing Hou; Menglei Ge; Yi Zhang; Lei Fan; Yingying Pei; Li Yu; Guanhua Xue; Lijuan Ma; Hongmei Sun
Journal:  Front Cell Infect Microbiol       Date:  2022-04-29       Impact factor: 6.073

2.  Clinical significance of respiratory virus coinfection in children with Mycoplasma pneumoniae pneumonia.

Authors:  Soojeong Choo; Yun Young Lee; Eun Lee
Journal:  BMC Pulm Med       Date:  2022-05-30       Impact factor: 3.320

3.  Effect of pidotimod combined with azithromycin on children with mycoplasma pneumonia and the expression levels of IL-10 and G-CSF in serum.

Authors:  Hongxing Shi; Limin Lan; Xianghong Lv; Lizhi Sun
Journal:  Exp Ther Med       Date:  2019-07-03       Impact factor: 2.447

4.  Acute saddle pulmonary embolism: A rare complication of mycoplasma pneumonia.

Authors:  Farrah Chilet; Arshad Muhammad Iqbal; Nikolay Mitzov; Abdulmagid Eddib; Salman Muddassir
Journal:  Respir Med Case Rep       Date:  2020-03-04

5.  Metabolomic analysis reveals potential biomarkers and the underlying pathogenesis involved in Mycoplasma pneumoniae pneumonia.

Authors:  Jieqiong Li; Laurence Don Wai Luu; Xiaoxia Wang; XiaoDai Cui; Xiaolan Huang; Jin Fu; Xiong Zhu; Zhenjun Li; Yi Wang; Jun Tai
Journal:  Emerg Microbes Infect       Date:  2022-12       Impact factor: 7.163

6.  Dynamic change of Mycoplasma pneumoniae pneumonia in hospitalized children in a general hospital: a 3-year retrospective analysis.

Authors:  Yan Xing; Dan Wang; Kai Sheng; Xiumei Xiao; Hongling Wei; Ling Liu; Wei Zhou; Xiaomei Tong
Journal:  Transl Pediatr       Date:  2020-08
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.